[HTML][HTML] Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease

CA Labarrere, GS Kassab - Frontiers in Microbiology, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus
disease 19 (COVID-19) has numerous risk factors leading to severe disease with high …

[HTML][HTML] A perspective study of the possible impact of obeticholic acid against SARS-CoV-2 infection

GES Batiha, HM Al-Kuraishy, AI Al-Gareeb… - …, 2023 - Springer
The causative agent of CoV disease 2019 is a new coronavirus CoV type 2, affecting the
respiratory tract with severe manifestations (SARS-CoV-2). Covid-19 is mainly symptomless …

The potential impact of Covid-19 on CNS and psychiatric sequels

A Dehghani, E Zokaei, SM Kahani, E Alavinejad… - Asian Journal of …, 2022 - Elsevier
Due to its high prevalence and fatality, the current Severe Acute Respiratory Syndrome-
coronavirus-2 (SARS-CoV-2) virus, which first emerged in China in 2019, quickly spread …

Mixed storm in SARS‐CoV‐2 infection: a narrative review and new term in the Covid‐19 era

BM Alomair, HM Al‐Kuraishy… - Immunity …, 2023 - Wiley Online Library
Abstract Coronavirus disease 2019 (Covid‐19) is caused by a novel severe acute
respiratory syndrome coronavirus virus type 2 (SARS‐CoV‐2) leading to the global …

[HTML][HTML] The efficacy of antioxidant oral supplements on the progression of COVID-19 in non-critically ill patients: a randomized controlled trial

MMA Abulmeaty, GS Aljuraiban, SM Shaikh, NE ALEid… - Antioxidants, 2021 - mdpi.com
Modulation of cytokine production using immunonutrition is a relatively novel concept to
improve outcomes among patients with SARS-CoV-2 infection and is now hypothesized to …

[HTML][HTML] Deferoxamine has the potential to improve the COVID-19-related inflammatory response in diabetic patients

M Zeinivand, M Sharifi, G Hassanshahi… - International journal of …, 2023 - Springer
The clinical state of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
been considered a pandemic disease (COVID-19) that is rapidly spreading worldwide …

[HTML][HTML] The critical impacts of cytokine storms in respiratory disorders

SR Tramboo, AME Elkhalifa, S Quibtiya, SI Ali… - Heliyon, 2024 - cell.com
Cytokine storm (CS) refers to the spontaneous dysregulated and hyper-activated
inflammatory reaction occurring in various clinical conditions, ranging from microbial …

Current landscape of mesenchymal stem cell therapy in COVID induced acute respiratory distress syndrome

A Chanda, A Aich, A Sanyal, A Chandra… - arXiv preprint arXiv …, 2022 - arxiv.org
The severe acute respiratory syndrome coronavirus 2 outbreak in Chinas Hubei area in late
2019 has now created a global pandemic that has spread to over 150 countries. In most …

The COVID-19 Illness: Addressing the Current Treatment Limitations and Care Gaps with a Novel Alternative and Complementary Agent-the Glutathione-Cyclodextrin …

RYDOPMS FACOFP - Alternative Therapies in Health and …, 2023 - search.proquest.com
We are approaching the fourth year of the COVID-19 pandemic. Although great progress
has been made in addressing the SARS-CoV-2 infection, there are significant treatment …

Hispidulin exerts a protective effect against oleic acid induced-ARDS in the rat via inhibition of ACE activity and MAPK pathway

K Koc, NS Ozek, F Aysin, O Demir… - International Journal …, 2024 - Taylor & Francis
This study investigates the protective role of Hispidulin on acute respiratory distress
syndrome (ARDS) in rats. Rats were divided into three groups: control, ARDS, ARDS+ …